Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD

H. Keir (Dundee, United Kingdom), A. Dicker (Dundeegus), United Kingdom), M. Lonergan (DundeeAngus), United Kingdom), M. Crichton (Dundee, United Kingdom), B. Miller (Collegeville, United States of America), R. Tal Singer (Collegeville, United States of America), J. Chalmers (Dundee, United Kingdom)

Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4931
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Keir (Dundee, United Kingdom), A. Dicker (Dundeegus), United Kingdom), M. Lonergan (DundeeAngus), United Kingdom), M. Crichton (Dundee, United Kingdom), B. Miller (Collegeville, United States of America), R. Tal Singer (Collegeville, United States of America), J. Chalmers (Dundee, United Kingdom). Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD. 4931

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD
Source: Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020
Year: 2020



Differences of clinical characteristics and phenotype between biomass and tobacco related COPD
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Clinical phenotypic differences between COPD and asthma in elderly patients
Source: Eur Respir J 2004; 24: Suppl. 48, 60s
Year: 2004

Sources of origin of the oropharyngeal microbiota in patients with different phenotypes of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



Different pattern of systemic and local inflammation in patients with exacerbation of COPD with different body composition
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



Clinical and functional characteristics of the natural course of COPD
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Relationship between the respiratory microbiome and systemic patterns in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Cluster analysis revealed differences on quality of life and susceptibility to exacerbation between subpopulations of smokers including COPD
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011


Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002

Azurocidin-1: a marker of COPD severity and microbial dysbiosis
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


The relationship of exacerbations and lung function decline to radiologic characteristics in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Using characteristics of asthma phenotypes to determine exacerbation severity
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Asthma and COPD: similarities and differences in pathogenesis
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016

What is the evidence that ethnic differences in the prevalence of respiratory disease are explained by differences in genetic make-up?
Source: International Congress 2015 – Respiratory disease in minority groups
Year: 2015



Clinical characteristics, physical function, physical activity and their associations with body composition phenotypes in patients with COPD.
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018




Changes in the cellular composition of induced sputum in patients with asthma-COPD overlap
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019


Lower airway bacterial colonization patterns and species-specific interactions in COPD
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018